TOR controls transcriptional and translational programs via Sap-Sit4 protein phosphatase signaling effectors

John R. Rohde, Susan Campbell, Sara A. Zurita-Martinez, N. Shane Cutler, Mark Ashe, Maria E. Cardenas

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The Tor kinases are the targets of the immunosuppressive drug rapamycin and couple nutrient availability to cell growth. In the budding yeast Saccharomyces cerevisiae, the PP2A-related phosphatase Sit4 together with its regulatory subunit Tap42 mediates several Tor signaling events. Sit4 interacts with other potential regulatory proteins known as the Saps. Deletion of the SAP or SIT4 genes confers increased sensitivity to rapamycin and defects in expression of subsets of Tor-regulated genes. Sap155, Sap185, or Sap190 can restore these responses. Strains lacking Sap185 and Sap190 are hypersensitive to rapamycin, and this sensitivity is Gcn2 dependent and correlated with a defect in translation, constitutive eukaryotic initiation factor 2α hyperphosphorylation, induction of GCN4 translation, and hypersensitivity to amino acid starvation. We conclude that Tor signals via Sap-Sit4 complexes to control both transcriptional and translational programs that couple cell growth to amino acid availability.
    Original languageEnglish
    Pages (from-to)8332-8341
    Number of pages9
    JournalMolecular and Cellular Biology
    Volume24
    Issue number19
    DOIs
    Publication statusPublished - Oct 2004

    Fingerprint

    Dive into the research topics of 'TOR controls transcriptional and translational programs via Sap-Sit4 protein phosphatase signaling effectors'. Together they form a unique fingerprint.

    Cite this